Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583
Stopped early
Conditions studied: Prostate Cancer
In brief
RATIONALE: Studying samples of blood and urine from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This laboratory study is measuring plasma and urine biomarkers in patients with advanced prostate cancer that did not respond to hormone therapy.
Key facts
- Study ID
- NCT00898833
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 868
- Starts
- 2003-07-01
- Expected to finish
- 2016-06-01
- Last updated by the study team
- 2017-08-08
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Roswell Park Cancer Institute — Buffalo, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.